秦冲 | 博士 | 教授 | 博士生导师 | |
科 室: | 药物合成 | |||
电子邮箱: |
|
| qc@ouc.edu.cn | |
联系地址: | 青岛市崂山区香港东路23号350vip8888新葡的京集团浮山校区研究院C303 | |||
研究方向: | 1. 基于靶向蛋白降解(PROTACs)策略的小分子先导化合物发现和新药发现 2. 去势抵抗性前列腺癌治疗药物研究 3. 海洋天然活性物质的结构多样性修饰及成药性优化 | |||
个人简介 |
|
|
|
|
教授,博士生导师,青岛海洋生物医药研究院副院长。主持国家高层次青年人才项目(2021)、国家重点研发计划青年科学家项目(2022)、国家自然基金青年基金(2021)、山东省“泰山学者”青年专家(2020)、山东省自然基金优秀青年基金(2021)等研究项目,获北京市自然科学奖一等奖(2019)。近年来在 J. Am. Chem. Soc.、Angew. Chem. Int. Ed.、J. Med. Chem. 等杂志发表学术论文二十余篇。 | ||||
教育背景 |
|
|
|
|
2010.09~2015.07 | 北京大学 | 药物化学 | 博士 (导师:焦宁教授) | |
2006.09~2010.06 | 中国农业大学 | 应用化学 | 学士 | |
工作经历 |
|
|
|
|
2019.09至今 | 350vip8888新葡的京集团 | 教授 |
| |
2016.01~2019.09 | 美国密歇根大学 | 博士后 | 导师:Shaomeng Wang | |
荣誉奖励 北京市自然科学奖一等奖(2019) 主讲《高等药物化学》研究生课程获教育部“拓金计划”示范课程(2022)、山东省研究生教育优质课程(2021) 北京大学学生五四奖章(2014) 课题组主页(The Qin Group @OUC): http://qin.qdmbri.com/ ResearchGate: https://www.researchgate.net/profile/Chong-Qin-7 | ||||
代表性成果 | ||||
代表性论文(*corresponding author): | ||||
Yan Lv+, Zixuan Yang+, Yiming Chen+, Xuepei Ma, Mengqi Guo, Chengwei Zhang, Xiaolin Jiang, Chengli Wang, Zhuoyue Li, Zhengfu Tai, Xiao Wang, Siqi Zhang*, Shumin Ma*, Chong Qin*. A Potent SOS1 PROTAC Degrader with Synergistic Efficacy in Combination with KRASG12C Inhibitor. J. Med. Chem. 2024, 10.1021/acs.jmedchem.3c01598. (IF: 8.039). Simin Sun+, Zhuoyue Li+, Chao Huang, Jinyu Liu, Qixin Yu, Xiaolin Jiang, Kairui Yue, Jianchun Zhao, Tongqiang Xu, Yankai Liu, Xiaoyang Li*, Chong Qin*, Yuqi Jiang*. Discovery of Novel 2,3-Dihydro-1H-indene-5-sulfonamide NLRP3 Inflammasome Inhibitors Targeting Colon as a Potential Therapy for Colitis. J. Med. Chem. 2023, 66, 16141–16167. (IF: 8.039). Zhuoyue Li+, Yiming Chen+, Xiaolin Jiang+, Penghui Lu, Chengli Wang, Zhimin Li, Xinyue Yu, Zixuan Yang, Shumin Ma, Shanshan Du, Zhengfu Tai, Xiaoyang Li*, Siqi Zhang*, Yuqi Jiang*, Chong Qin*. Novel Sulfonylurea-Based NLRP3 Inflammasome Inhibitor for Efficient Treatment of Nonalcoholic Steatohepatitis, Endotoxic Shock, and Colitis. J. Med. Chem. 2023, 66, 12966–12989. (IF: 8.039). Bowen Zhang+, Chang Liu+, Zhenqian Yang+, Sai Zhang+, Xiaolin Hu, Baohu Li, Mei Mao, Xiao Wang, Zhuoyue Li, Shumin Ma, Siqi Zhang, and Chong Qin*. Discovery of BWA-522, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer. J. Med. Chem. 2023, 66, 11158-11186. (IF: 8.039) Siqi Zhang+, Xiaolei Meng+, Sai Zhang+, Baohu Li, Wencong Jin, Chengwei Zhang, Zhaojuan Liu, Xiaolin Hu, Ling Ge, Zhonghao Yu, Zhuoyue Li, Shumin Ma, Xiao Wang, Liming Li, Chong Qin*. Design, Synthesis and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (Hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant Prostate Cancer. J. Med. Chem. 2023, 66, 4784–4801. (IF: 8.039) Liming Li+*, Heping Zheng+, Xuepei Ma, Jie Bai, Shumin Ma, Zhuoyue Li, Chong Qin*. Inhibition of Astrocytic Carbohydrate Sulfotransferase 15 Promotes Nerve Repair After Spinal Cord Injury via Mitigation of CSPG Mediated Axonal Inhibition. Cell. Mol. Neurobiol. 2023, 43, 2925–2937. (IF: 4.231) Qiang Wang, Baohu Li, Wenkai Zhang, Zhuoyue Li, Bo Jiang*, Sichuan Hou*, Shumin Ma*, Chong Qin*, Lethal Activity of BRD4 PROTAC Degrader QCA570 Against Bladder Cancer Cells. Front. Chem. 2023, doi.org/10.3389/fchem.2023.1121724. (IF: 5.545) Ruxuan Wang, Tengjiang Zhong, Qiong Bian, Sai Zhang, Xiaolu Ma, Liming Li, Yihua Xu, Yueting Gu, Anran Yuan, Weitong Hu, Chong Qin*, Jianqing Gao*, PROTAC Degraders of Androgen Receptor-Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration. Small Methods. 2023, 7, 2201293. (IF: 14.188) Chong Qin and Ning Jiao*, Iron-Facilitated Direct Oxidative C−H Transformation of Allylarenes or Alkenes to Alkenyl Nitriles. J. Am. Chem. Soc. 2010, 132, 15893-15895; Chong Qin, Wang Zhou, Feng Chen, Yang Ou and Ning Jiao*, Iron-catalyzed C-H and C-C Bond Cleavage: A Direct Approach to Amides from Simple Hydrocarbon Molecules, Angew. Chem. Int. Ed. 2011, 50, 12595-12599; Chong Qin, Tao Shen, Conghui Tang and Ning Jiao*, FeCl2-promoted Unactivated C-C Bond Cleavage of Alkylarenes and Polystyrene: Direct Synthesis of Versatile Arylamines, Angew. Chem. Int. Ed. 2012, 51, 6971-6975; Chong Qin, Peng Feng, Yang Ou, Tao Shen, Teng Wang and Ning Jiao*, Highly Selective Csp2-Csp Bond Cleavage: The Nitrogenation of Alkynes to Amides. Angew. Chem. Int. Ed. 2013, 52, 7850-7854; Chong Qin,+ Yijin Su,+ Xiaodong Shi and Ning Jiao*, Splitting a Substrate into Three Parts: Gold-Catalyzed Nitrogenation of Alkynes by C-C and C≡C Bond Cleavage. Angew. Chem. Int. Ed. 2016, 55, 350-354; Chong Qin,+ Yang Hu,+ Bing Zhou,+... Shaomeng Wang*, Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression. J. Med. Chem. 2018, 61, 6685–6704;
| ||||
项目课题 | ||||
1. 国家高层次青年人才项目,300万,2022.1-2024.12,主持; 2. 国家重点研发计划青年科学家项目(2022YFC2804400),200万,2022.11-2025.10,主持; 3. 国家自然科学基金青年基金(22107095),30万,2022.1-2024.12,主持; 4. 山东省“泰山学者”青年专家(tsqn201909171),100万,2020.01-2024.12,主持; 5. 山东省自然科学基金优秀青年基金(22107095),40万,2022.1-2024.12,主持。 | ||||
【关闭】